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Abstract
5T4 oncofetal molecules are highly expressed during development and upregulated in cancer while showing only low levels
in some adult tissues. Upregulation of 5T4 expression is a marker of loss of pluripotency in the early differentiation of
embryonic stem (ES) cells and forms an integrated component of an epithelial-mesenchymal transition, a process important
during embryonic development and metastatic spread of epithelial tumors. Investigation of the transcriptional changes in
early ES differentiation showed upregulation of CXCL12 and down-regulation of a cell surface protease, CD26, which cleaves
this chemokine. CXCL12 binds to the widely expressed CXCR4 and regulates key aspects of development, stem cell motility
and tumour metastasis to tissues with high levels of CXCL12. We show that the 5T4 glycoprotein is required for optimal
functional cell surface expression of the chemokine receptor CXCR4 and CXCL12 mediated chemotaxis in differentiating
murine embryonic stem cells and embryo fibroblasts (MEF). Cell surface expression of 5T4 and CXCR4 molecules is co-
localized in differentiating ES cells and MEF. By contrast, differentiating ES and MEF derived from 5T4 knockout (KO) mice
show only intracellular CXCR4 expression but infection with adenovirus encoding mouse 5T4 restores CXCL12 chemotaxis
and surface co-localization with 5T4 molecules. A series of chimeric constructs with interchanged domains of 5T4 and the
glycoprotein CD44 were used to map the 5T4 sequences relevant for CXCR4 membrane expression and function in 5T4KO
MEF. These data identified the 5T4 transmembrane domain as sufficient and necessary to enable CXCR4 cell surface
expression and chemotaxis. Furthermore, some monoclonal antibodies against m5T4 can inhibit CXCL12 chemotaxis of
differentiating ES cells and MEF which is not mediated by simple antigenic modulation. Collectively, these data support a
molecular interaction of 5T4 and CXCR4 occurring at the cell surface which directly facilitates the biological response to
CXCL12. The regulation of CXCR4 surface expression by 5T4 molecules is a novel means to control responses to the
chemokine CXCL12 for example during embryogenesis but can also be selected to advantage the spread of a 5T4 positive
tumor from its primary site.
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Introduction
5T4 oncofetal glycoprotein was discovered while searching for
molecules with invasive properties likely to be shared by trophoblast
and cancer cells [1]. It is expressed by many different carcinomas
while showing only low levels in some normal tissues [2]. 5T4
expression has been shown to influence adhesion, cytoskeletal
organization and motility [3,4,5], properties which might account
for its association with poorer clinical outcome in some cancers
[6,7,8,9]. Its <72 kD transmembrane molecules have a short
cytoplasmic region, as well as an N-glycosylated extracellular
domain with two leucine rich repeat (LRR) regions separated by a
hydrophilic sequence and associated N and C terminal flanking
regions [10,11]. LRR are found in proteins with diverse functions
and are frequently associated with protein-protein interaction [12].
We have recently shown that upregulation of 5T4 expression is a
marker of loss of pluripotency in the early differentiation of human
and murine embryonic stem cells [13,14] and forms an integrated
component of an epithelial-mesenchymal transition (EMT) [15,16].
EMT occurs during embryonic development and is also believed to
be important for the metastatic spread of epithelial tumors [17]. To
further study this process we conducted a comparative microarray
analysis of undifferentiated (5T4 –ve) and early differentiating (5T4
+ve) murine ES cells [18]. 5T4 is up-regulated at an earlier stage of
ES differentiation than the widely used down-regulation of the
SSEA-1 marker [13] while cell sorting for surface 5T4 expression
provided an additional level of stringency in the definition of ES cell
populations compared to stratifications used in some other
microarray studies [19,20]. Any transcriptional changes may be
important in governing the balance of self-renewal/pluripotency
and differentiation in ES cells, or in the regulation of 5T4 cell
surface expression. Such properties may also be functionally
important in tumor progression. One significant transcriptional
change identified was the down-regulation of transcripts for the
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e9982dipeptidyl peptidase IV, CD26, which code for a cell surface
protease that cleaves the chemokine CXCL12 [21]. Interestingly,
differentiating ES cells also showed an upregulation of CXCL12
transcription. CXCL12 has been shown to regulate many biological
processes but also plays an important role in tumorigenesis [22,23].
CXCL12 binds to the widely expressed cell surface seven
transmembrane domain G-protein coupled receptor CXCR4
[24,25] and to the recently identified receptor CXCR7/RDC1
[26]. Upon ligand binding, CXCR4 undergoes a conformational
change that facilitates activation of heterotrimeric G proteins and
signaling effectors at the plasma membrane [27]. This initiates a
signaling cascade resulting in downstream phosphorylation of
proteins such as ERK1/2 and AKT [28,29]. These activities are
dependent on CXCR4 expression at the plasma membrane and
cellular events that reduce the latter can abrogate the biological
effects. Following activation, CXCR4 undergoes b-arrestin-medi-
ated endocytotosis and althoughrecycling of CXCR4canoccur this
receptor can also be ubiquinated and directed to lysosomes where it
is degraded [30,31]. Both CXCL12 and CXCR4 expression have
been associated with tumorigenesis in many cancers including
breast, ovarian, renal, prostate, and neuroblastoma [22,23,24].
These CXCR4 expressing tumors preferentially spread to tissues
that highly express CXCL12, including lung, liver, lymph nodes
and bone marrow [22,23,24]. Therefore, the inverse correlation
between 5T4 and CXCL12 with CD26 transcript levels during
mouse ES cell differentiation, and the known roles of these
molecules in cell migration/motility, may suggest that particular
regulatory processes are common to both ES cell differentiation and
tumor metastasis. This article reports the unexpected discovery that
5T4 molecules are required for functional expression of CXCR4 at
the cell surface of differentiating ES cells, and mouse embryonic
fibroblasts (MEF).
Results
Microarray analysis of differentiating mES cells stratified
by cell surface 5T4 phenotype
Analysis of the microarray data from undifferentiated and
differentiating E14 ES cells identified significant up or down
regulation of transcripts in 148 and 277 genes respectively (GEO
accession number GSE20372). There was a pattern of transcrip-
tional changes relating to a loss of pluripotency in ES cells with
significant (adjusted P value ,0.1) downregulation of Klf4 (18.4x),
Oct4 (1.66) and Sox2 (1.96). Many genes known to bind these
transcription factors and form part of the extended transcriptional
network influencing pluripotency of ES cells were also found to be
downregulated [32,33]. These are approximately 25% of the
significantly downregulated genes and include 77 which can bind
one or more of these transcription factors. The complex changes in
transcription seen in the differentiating ES cells analyzed here
reflect the several different pathways that can control ES cell
pluripotency and self-renewal. In respect of this report, the
microarray data indicated a significant downregulation of Dpp4
also called Cd26 (6.26), upregulation of Cxcl12 (3.46) but no
change in the transcripts of Cxcr4. CD26 is a surface peptidase
which cleaves CXCL12 chemokine and CXCR4 is the receptor of
the latter. We decided to further investigate whether this was of
functional significance.
Differentiating mES cells show 5T4-dependent CXCL12
chemotaxis
The latter microarray data were confirmed by qPCR (Figure 1A)
and FACS analysis showed that as the ES cells differentiate cell
surface expression of CD26 decreases while 5T4 increases; by
contrast the pluripotent ES marker SSEA-1 did not significantly
change over this time (Figure 1B). Consistent with the transcript
analysis, western blotting shows there is no change in the total
CXCR4 expression upon differentiation of either wild-type (WT)
or 5T4 knock out (5T4KO)-ES cells (Figure 1C). A greater than 2
fold increase in CXCL12 was detected in the culture medium by
ELISA after 3 days of differentiation of WT (7164 vs 17169 pg/
ml) or 5T4KO (4062v s8 4 65 pg/ml) ES cells, (Figure 1D). These
data demonstrate that in early differentiation of ES ells there is
increased CXCL12 ligand production and decreased expression of
CD26 dipeptidase that can destroy its activity but there is no
change in either the CXCR4 transcript or protein levels,
consistent with the microarray results.
To examine biological response to CXCL12, WT and 5T4KO-
ES cells were tested for CXCL12 chemotaxis before and after
differentiation. Both WT and 5T4KO undifferentiated ES cells
showed no chemotaxis towards CXCL12. Upon differentiation
WT-ES cells showed a .2-fold response, while 5T4KO-ES cells
remained unresponsive (Figure 1E). Following LIF withdrawal,
both WT and 5T4KO-ES cells undergo an EMT with the tightly
packed ES colonies becoming dispersed with the differentiating
cells showing an arborized morphology. Although the differenti-
ating 5T4KO-ES cells show reduced motility [16], their failure in
chemotaxis was not a result of delayed kinetics in response since
daily testing for up 6 days still provided no evidence for CXCL12
dependent chemotaxis (data not shown). The specificity of the
chemotaxis was confirmed by showing that the differentiated WT-
ES cell chemotaxis to CXCL12 was blocked by specific antibodies
to the chemokine (Figure 1F) and by blocking the CXCR4
receptor with the inhibitor AMD3100 (Figure 1G). Further, the
lack of chemotaxis of differentiating 5T4KO-ES cells was not the
result of continued CD26 activity destroying CXCL12, since pre-
incubation with the competitive CD26 inhibitor diprotin A did not
restore chemotactic behavior (Figure 1H). To test whether 5T4
might play a role in CXCL12 dependent chemotaxis, undifferen-
tiated and differentiating 5T4KO-ES cells were infected with
recombinant adenoviral vector encoding mouse 5T4 (RAd-m5T4)
or RAd-GFP control vector. There was no change in chemotaxis
of either WT or 5T4KO undifferentiated ES cells infected with the
different vectors (Figure 2A). Expression of m5T4 in differentiating
5T4KO-ES cells restores CXCL12 chemotaxis comparable to that
of differentiating WT-ES cells (Figure 2B). A recombinant
adenovirus encoding human 5T4 also restored chemotaxis
(Figure 2C). These data suggest that 5T4 expression is a necessary
cofactor for CXCR4 functional expression and CXCL12
chemotaxis in differentiating ES cells. One mechanism that might
account for these results would be if 5T4 molecules facilitate stable
cell membrane expression of CXCR4 molecules in differentiating
ES cells.
5T4 expression influences plasma membrane expression
of CXCR4 in differentiating ES cells
The expression and cellular localization of 5T4 and CXCR4
molecules before and after differentiation of WT and 5T4KO-ES
cells was determined by immunofluorescence of fixed cells grown
on glass plates (Figure 3A). Undifferentiated WT-ES cells are 5T4-
negative with CXCR4 expression low and intracellular however
following differentiation both molecules can be detected at the cell
surface with clear areas of co-localization. By contrast, differen-
tiated 5T4KO ES cells show only intracellular CXCR4 expres-
sion. Quantitatively, 98% of differentiating WT-ES cells showed
cell surface CXCR4 expression and only 2% cytoplasmic while
differentiating KO-ES had 1% cell surface and 89% cytoplasmic
CXCR4 labeling; 10% were CXCR4 negative. It is apparent that
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PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e9982Figure 1. Differentiating mES cells show 5T4 dependent CXCL12 chemotaxis. (A), Triplicate quantitative RT-PCR of WT-ES cells after 3 days
differentiation with significant changes in 5T4, CD26 and CXCL12 mRNA but not CXCR4 respectively P=0.014, 0.057, 0.81, 0.012 by Student’s t-test.
(B), Flow cytometry analysis of WT-ES cell differentiation 5T4 (triangles), CD26 (circles) and SSEA-1 (diamonds) (n.3 a single representative time
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in differentiating WT but not 5T4KO differentiating ES cells
where CXCR4 remains intracellular. However, when differenti-
ating 5T4KO-ES cells are infected with RAd-m5T4, CXCR4 can
be detected at the cell surface co-localized with 5T4 molecules
(Figure 3B). RAd-m5T4 infected undifferentiated WT-ES cells
show only limited CXCR4 and 5T4 surface expression in a few
outer cells of undifferentiated ES colonies. These are most likely
spontaneously differentiating cells suggesting that differentiation is
a necessary cofactor for co-localization/expression of CXCR4 and
5T4 at the cell surface. In differentiating 5T4KO-ES cells,
CXCR4 accumulated in the Golgi and to a lesser extent in smooth
endoplasmic reticulum (Figure 3C). These data are consistent with
5T4 molecules being necessary for the surface expression of the
CXCR4 receptor and chemotaxis to CXCL12 in differentiating
ES cells. These properties were further explored using MEF
derived from WT and 5T4KO mice.
CXCR4 cell surface expression, CXCL12 mediated ERK
signaling and chemotaxis are 5T4 dependent in mouse
embryo fibroblasts
A 5T4 dependency for CXCR4-mediated chemotaxis is also
apparent in MEF as shown by: (1) a 5T4 gene dose influence on
CXCL12 chemotaxis in WT, heterozygote and 5T4KO MEF
(Figure 4A); (2) the restoration of the chemotactic response of
5T4KO MEF by RAd-m5T4 (Figure 4B); and (3) the co-
localization of some CXCR4 molecules with typical 5T4 cell
surface expression in WT MEF while 5T4KO MEF show only
intracellular CXCR4 (Figure 4C) that can be rescued at the cell
surface by RAd-m5T4 (Figure 4D). Detailed analysis of individual
cells in this experiment documented 98% of WT MEF showing all
CXCR4 at the cell surface. By contrast, 76% of 5T4KO MEF
showed either CXCR4 perinuclear or cytoplasmic labeling and
only 2% with any apparent membrane associated labeling; in 22%
5T4KO MEF CXCR4 was not detected.
CXCL12 activates the MAPK/ERK signal transduction
pathway. We therefore examined the requirement for 5T4 in
the activation of this pathway in WT and 5T4KO MEF (Fig. 5).
Stimulation of WT MEF with the chemokine CXCL12 induced
the phosphorylation of the key intracellular effector ERK1/2. The
activation of ERK1/2 by CXCL12 was prevented by using a
specific inhibitor of either an upstream kinase MEK (PD98059;
Figure 5, Lane M) or of CXCR4 (AMD3100; Figure 5, Lane M)
but not by an inhibitor of PI3K (LY294002; Figure 5, Lane P) in a
different signaling pathway, demonstrating that signal transduc-
tion was dependent upon CXCR4 mediated activation of the
MAPK/ERK pathway. In 5T4KO MEF, CXCL12 activation did
not lead to ERK1/2 phosphorylation, however this was not due to
an overall disruption of the MAPK/ERK pathway as Phorbol 12-
Myristate 13-Acetate, (PMA) stimulation led to a MEK but not
CXCR4 dependent phosphorylation of ERK1/2 in both geno-
types. These data demonstrate that in WT MEF a classical signal
transduction pathway evoked by CXCL12 mediated activation of
CXCR4 is functional. However, in the absence of 5T4, the
chemokine receptor is no longer able to activate this pathway and
the phosphorylation status of ERK1/2 is not responsive to
CXCL12.
The transmembrane domain of 5T4 is necessary for
CXCR4 cell surface expression
In the embryonic cells investigated it appears that cell surface
expression of, and chemotactic response through, CXCR4 can be
regulated by 5T4 expression. To examine the role of the
extracellular, transmembrane and cytoplasmic domains of 5T4
molecules in CXCR4 surface expression, a series of murine 5T4
gene plasmid constructs were generated and cloned into a
retrovirus also encoding eGFP as a reporter gene. 5T4KO MEF
were infected with the retroviral constructs and cells were
examined for both eGFP expression and CXCR4 localization by
immunofluorescence (Figure 6). 5T4KO fibroblasts (controls,
Figure 6A, panel i-iv) infected with retroviruses encoding full-
length 5T4 (Figure 4a, panels v-viii) showed surface expression of
CXCR4. However, the 5T4 extracellular domain was insufficient
(Figure 6A, panels ix-xii) and the cytoplasmic domain unnecessary
(Figure 6A, panels xiii-xvi) for CXCR4 expression on the cell
surface. To test whether the 5T4 transmembrane domain (TM)
was necessary and sufficient for cell surface CXCR4 expression,
chimeric constructs of mouse 5T4/CD44 molecules with recipro-
cally exchanged TM and cytoplasmic domains were engineered.
CD44 gene was selected for this experiment since, similarly to
5T4, it is a transmembrane glycoprotein, involved in adhesion and
motility. It is constitutively expressed in MEF with no effect on
surface CXCR4 expression. Importantly, cells infected with the
retrovirus encoding the 5T4 extracellular domain fused to the
transmembrane and cytoplasmic region of CD44 exhibited no cell
surface expression of CXCR4 (Figure 6A, panels xvii-xx), whereas
the reciprocal construct did promote cell surface expression of
CXCR4 (Figure 6A, panels xxi-xxiv). Similar results were obtained
with transfection of the plasmid constructs, confirming that these
results were not an artifact of the viral infections (not shown). More
importantly, when the biological function of these cells were
assessed there was a clear correlation between the ability of the
constructs to promote cell surface expression of CXCR4 and their
ability to migrate towards CXCL12 (Figure 6B). Only constructs
which contained the TM of 5T4 exhibited both cell surface
expression of CXCR4 and CXCL12 mediated chemotaxis.
Together these observations suggest that the transmembrane
region of the 5T4 glycoprotein is required for the surface
expression of CXCR4 in MEF and consequently their ability to
respond to CXCL12 chemotactically.
Effects of cytoskeleton, microtubule and Golgi disruption
on the co-localization pattern of 5T4 and CXCR4
To document the basic components of trafficking, primary WT
MEF were treated for 24 hours with cytochalasin D, brefeldin A or
nocodazole to disrupt the cytoskeleton, Golgi or microtubules
respectively and the pattern of 5T4 and CXCR4 expression was
determined before and after washout of the drugs. The
course shown). (C), Western blot analysis of PAGE separated reduced WT or 5T4KO-ES cells either undifferentiated (U) or differentiating (D) probed
with CXCR4 antibody. (D), Murine CXCL12 specific ELISA of conditioned medium from undifferentiated (white columns) and differentiating (black
columns) WT and 5T4KO-ES cells. (E), Undifferentiated WT and 5T4KO-ES cells (white columns) exhibit no CXCL12 chemotaxis. Differentiating (black
columns) WT, but not 5T4KO-ES cells, acquire significant chemotaxis. (F), CXCL12 chemotaxis in differentiating WT-ES cells (black columns) is blocked
by an antibody against CXCL12; undifferentiated ES cells (white columns) show no chemotaxis. (G), Chemotaxis of differentiating WT-ES cells, (black
columns) is blocked by a 2hr pre-incubation with 10 mM AMD3100; with no effect on undifferentiated WT-ES cells (white columns). (H),
Undifferentiated (white columns) or differentiating (black columns) 5T4KO-ES cells show no change in chemotactic response in the presence of the
CD26 inhibitor diprotin A (DPA, 10 mM).
doi:10.1371/journal.pone.0009982.g001
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immunofluorescence with flurochrome conjugated phalloidin,
NBD C6 ceramide and antibodies against b-tubulin respectively
(not shown). Untreated primary MEF exhibit cell surface
expression of both 5T4 and CXCR4 with considerable co-
localization (Figure 7). After cytochalasin D treatment, there was
no reduction in the CXCR4 cell surface expression or co-
localization of 5T4 and possibly an increase compared to
untreated controls. Brefeldin A reduced levels of cell surface
expression of both antigens and all residual CXCR4 or 5T4
labeling was co-localized at cell surface. One hour after brefeldin
A washout, increased cell surface expression of both antigens with
marked cell surface co-localization was observed. Following
nocodazole treatment there was some intracellular accumulation
but no cell surface detection of CXCR4. 5T4 remained detectable
at the cell surface albeit at a diminished level and no co-
localization with CXCR4 was visible. One hour after nocodazole
washout both antigens were detectable at the cell surface with
marked co-localization. Clearly, detection of plasma membrane
co-localized 5T4/CXCR4 molecules is dependent on microtu-
bules and the molecules are not obligatorily associated at the
Golgi. Disruption of the Golgi or the actin cytoskeleton per se does
not disrupt all 5T4/CXCR4 co-localization at the plasma
membrane. It appears that CXCR4 and 5T4 molecules can form
a stable interaction at the cell surface facilitating the biological
response to CXCL12.
Inhibition of CXCL12 chemotaxis by monoclonal
antibodies recognizing m5T4 in mouse embryonic cells
5T4 molecules play a role in stabilizing plasma membrane
expression of CXCR4 receptors most likely through interaction of
their transmembrane domains. It is possible that the binding of
antibodies recognizing the extracellular domains of 5T4 molecules
might influence 5T4-CXCR4 interactions through modulation of
cell surface expression or altering conformation. We investigated
the ability of several different monoclonal antibodies to m5T4 to
influence the chemotactic response of differentiating ES cells or
MEF to CXCL12. Five different monoclonal antibodies recogniz-
ing distinct epitopes in the proximal and distal LRR domains of
m5T4 were available (Figure 8A). Each antibody showed different
affinity in a m5T4 specific ELISA (Figure 8B) or B16m5T4 FACS
titration (Figure 8C), decreasing in the order B3F1, P1C9, B5C9,
P1H10 and B1C3. All detect the extracellular domain of m5T4-Fc
by western blotting except for B1C3 (Figure 8D). Importantly, the
chemotactic migration towards CXCL12 exhibited by differenti-
ating WT-ES cells was abolished in the presence of mAb B1C3 but
not P1C9 or P1H10 while B3F1 and B5C9 showed less but still
significant inhibition of the chemotactic response (Figure 9A).
Figure 9B shows titration of antibody inhibition of differentiating
ES cell chemotaxis for the mAbs; the IC50 for the maximally
inhibitory mAb B1C3 was 0.36 mg, 60.11 and for B3F1 and
B5C9 was 2.2 mg60.8 and 6.8 mg61.5 respectively. The inhibi-
tion of chemotaxis by the mAb B1C3 was prevented by the
presence of m5T4-Fc (not shown). Similar results were exhibited
by primary WT MEF for four of the monoclonal antibodies tested
(Figure 9C). Thus, the chemotactic response of both differentiated
ES cells and MEF can be blocked by some but not all antibodies
recognizing distinct parts or epitopes of m5T4 molecules.
Figure 2. 5T4 restores CXCL12 dependent chemotaxis in
differentiating 5T4KO-ES cells. (A). Undifferentiated 5T4KO-ES cells
forced to express 5T4 following infection with RAd-m5T4, (multiplicity of
infection =30, dark grey columns) show no CXCL12 dependent
chemotaxis comparable to undifferentiated WT-ES cells (black columns),
mock (white columns), or RAd-eGFP (light grey columns) infection. (B),
Differentiating 5T4KO ES cells with 5T4 expression restored by RAd-m5T4,
(multiplicity of infection =30, dark grey columns) show CXCL12
chemotaxis comparable to differentiating WT-ES cells (black columns)
butnot following mock(whitecolumns), orRAd-eGFP(light grey columns)
infection. (C), Differentiating 5T4KO-ES cells chemotactic response to
CXCL12is alsorestored following infection witha recombinant adenovirus
encoding human 5T4 (multiplicity of infection =30, black columns).
doi:10.1371/journal.pone.0009982.g002
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modulate cell surface 5T4 expression was tested. Flow cytometry
analysis showed no significant differences in the modulation of cell
surface expression of 5T4 molecules after 2 or 24 hours by P1C9
and B1C3 mAbs as assessed in B16m5T4 cells (data not shown).
To assess any differential influence on recycling of CXCR4
molecules at the cell surface, MEF were treated with nocodazole to
remove CXCR4 membrane expression and allowed to recover in
the presence of either P1C9 or B1C3 mAbs. There was no
significant difference in recovery of CXCR4 membrane expression
in the presence of non-inhibitory P1C9 or inhibitory B1C3 mAb
after 3 or 6 hours (data not shown). These data suggest that the
influence of inhibitory 5T4 antibodies is not mediated through
preventing colocalization of 5T4 and CXCR4 at the cell surface.
5T4 facilitates CXCR6 but not CXCR3 or CXCR7 cell
surface expression and response to specific ligands
While the sequence variation across the extracellular chemokine
receptor domains may provide for ligand specificity, mechanisms
of transmembrane domain interaction with 5T4 molecules may be
shared with other molecules in the CXC receptor family. Since, in
addition to CXCL12 and CD26, the microarray data identified
significant upregulation of transcript levels in ES differentiation of
the chemokine CXCL10, and because CD26 is able to regulate
multiple chemokines, a role for 5T4 in the expression and function
of other chemokine receptors, including the CXCL10 receptor
CXCR3 [34] and the other CXCL12 receptor CXCR7, was
investigated.
The expression and cellular localization of 5T4 and CXCR6
molecules before and after differentiation was determined by
immunofluorescence of fixed ES cells grown on glass plates.
Undifferentiated WT-ES cells are 5T4-negative with CXCR6
expression low and intracellular. Following differentiation both
molecules can be detected at the cell surface with some areas of co-
localization (Figure 10A). To examine whether cell surface
expression of CXCR6 was biologically functional, undifferentiated
and differentiating WT and 5T4KO-ES cells were placed on a
chemotactic gradient towards the chemokine CXCL16, which is a
known ligand for CXCR6. Undifferentiated ES cells of either
genotype exhibited no chemotaxis towards CXCL16. In contrast,
differentiating WT-ES cells exhibited a significant increase in
chemotaxis towards CXCL16 whilst differentiating 5T4KO-ES
cells showed no functional chemotaxis towards CXCL16
(Figure 10B). This phenomenon was also evident in WT MEF
with co-localization of 5T4 and CXCR6 on the cell surface. By
contrast, 5T4KO MEF showed no cell surface expression of
CXCR6. Analysis of cell surface expression of CXCR6 by flow
cytometry confirmed results obtained by immunocytochemistry,
showing CXCR6 cell surface expression on WT but not 5T4KO
MEF (data not shown). Thus CXCR6 expression and its response
to the chemokine CXCL16 does require 5T4 expression in
embryonic mouse cells.
In contrast to CXCR4 and CXCR6, CXCR3 expression and its
response to its ligand CXCL10 does not require 5T4 expression.
Expression of CXCR3 is found at the cell surface of both WT and
5T4KO undifferentiated (not shown) and differentiating ES cells
(Figure 10C). However, a chemotactic response to CXCL10 is
only seen after differentiation in both WT and 5T4KO-ES cells
(Figure 10D). Further analysis of undifferentiated ES cells treated
with the inhibitor Diprotin A (10 mM) suggests that lack of
response in undifferentiated ES cells is partly due to CD26 activity
which can destroy CXCL10 [35] (data not shown). Treatment of
both WT and 5T4KO differentiating ES cells with the Gi protein
inhibitor pertussis toxin (10 ng/ml) showed that Gi protein-
chemokine receptor interaction occurs irrespective of 5T4
expression at the cell surface allowing CXCL10 chemotaxis (data
not shown).
Similarly cell surface expression of CXCR7 is also independent
of 5T4 cell surface expression. Undifferentiated ES cells (either
WT or 5T4KO) demonstrated both cytoplasmic and cell surface
expression of CXCR7 (Figure 11). In contrast following 3 days
under differentiating condition in WT-ES cells, CXCR7 is
relatively down-regulated from the cell surface whereas in
differentiating 5T4KO-ES surface CXCR7 is retained (Figure 11).
Discussion
In this study, we have demonstrated that in mouse differenti-
ating ES cells and embryonic fibroblasts, 5T4 glycoprotein plays a
critical role in the membrane expression of CXCR4 and the
chemotactic response to CXCL12. We first showed that during ES
cell differentiation, increased surface expression of 5T4 and
CXCL12 production was accompanied by decreased membrane
expression of the CXCL12 regulatory protease CD26 whereas
total cell levels of CXCR4 were unchanged. Studies with 5T4KO
and WT-ES cells and MEF established that 5T4 molecules are
required for cell surface expression and intracellular signaling of
the CXCL12 receptor CXCR4. Importantly, chemotaxis in
response to CXCL12 is disrupted in the absence of 5T4. The
5T4 dependency for CXCR4 plasma membrane expression and
co-localization studies support the direct molecular interaction of
CXCR4 and 5T4 molecules. The transmembrane region of 5T4 is
critical for this purpose as it was sufficient in the context of CD44
molecules to allow functional surface CXCR4 expression and
chemotaxis after introduction to 5T4KO MEF. Although
dependent on the TM of the 5T4 molecule, the precise nature
and stability of the interaction has not yet been ascertained. There
is evidence that CXCR4 molecules form homo- and heterodimers
[36] and LRR domains of the 5T4 molecules provide the
biochemical basis for formation of multimers [37] so the
stoichiometry is complicated to predict. It is possible that lipid
rafts and/or additional molecules may also be a component part of
a ‘‘functional’’ complex. The lifespan of the primary MEF have
limited availability for biochemical studies. Attempts to detect a
physical complex of 5T4 and CXCR4 have been successful in
Figure 3. Cellular location of CXCR4, 5T4 in undifferentiated and differentiating WT and 5T4KO-ES cells. (A), Shows lipid rafts in the
membrane of all cells (i, vi, xi, xvi); CXCR4 is intracellular in undifferentiated WT-ES and all 5T4KO-ES cells (ii, vii) and cell surface 5T4 is only expressed
on differentiation of WT-ES cells (xiv). The composite images (lipid = green, CXCR4 = red and 5T4 = blue) show co-localization of 5T4 and CXCR4
(purple) including in lipid rafts (white) in differentiating WT-ES cells (xiv) but no other cells (iv, ix, xix) (co-localized areas are shown in separate channel
(v, x, xv, xx)). (B), RAd-m5T4 infection of 5T4KO-ES cells leads to cell surface expression of both 5T4 and CXCR4 only in differentiating cells but not in
undifferentiated cells which are seen to co-localize (CXCR4 = green, 5T4 = red) in the composite (yellow)(co-localized areas are shown in separate
channel). RAd-GFP showed no effect on CXCR4 expression (not shown). (C), Upper panels, Double labeling of WT or 5T4KO-ES cells with either NBD
C6-Ceramide (Golgi) or Endotracker (ER) (both red) shows that in the absence of 5T4, CXCR4 (green) accumulates predominately in the Golgi and to a
lesser extent the smooth ER (yellow) whereas cell surface labeling is apparent only in the differentiating WT-ES cells)(lower panels: co-localized areas
are shown in separate channel).
doi:10.1371/journal.pone.0009982.g003
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and where pulldown and reciprocal western analyses suggest
association of some 5T4 and CXCR4 molecules in non-ionic
detergent solubilized lysates (Southgate et al unpublished). These
observations need further study using cross-linked membrane
preparations as well as FRET studies.
In order to distinguish where the CXCR4 and 5T4 interaction
might occur, we studied the effects of cytoskeleton, microtubule and
Golgi disruption on the co-localization pattern of the two molecules
in MEF. CXCR4 intracellular trafficking to the cell surface post
Golgi is dependent on the microtubules and not the actin
cytoskeleton. Once at the plasma membrane, co-localized CXCR4
Figure 4. Role of 5T4 expression in the CXC12/CXCR4 axis in MEF. (A), MEF derived from wild-type, (WT, black columns), 5T4 heterozygote,
(HET, grey columns) and 5T4 null, (5T4KO, white columns) embryos show 5T4 gene dose related CXCLl2 chemotaxis. (B), Chemotaxis of 5T4KO MEF
following mock infection, (black columns), or infection with RAd-eGFP, (grey columns), or RAd-m5T4, (white columns); CXCL12 chemotaxis is only
restored by RAd-m5T4. (+ or – 30 ng CXCL12). (C), Pattern of expression of CXCR4, (green) and 5T4, (red) in WT and 5T4KO MEF. In WT cells, CXCR4
and 5T4 are seen at the cell surface and clearly co-localize (CXCR4 = green; 5T4 = red; composite: co-localization = yellow; co-localized areas shown
in separate channel) while in 5T4KO cells CXCR4 is located intracellularly around the nucleus; compare to DAPI labeling (blue). (D), 5T4KO MEF
infected with RAd-m5T4 exhibit cell surface expression of both 5T4 and CXCR4 also displayed by co-localization (5T4=red; CXCR4 =green;
composite co localization= yellow; co-localized areas shown in separate channel). RAd-GFP had no effect on CXCR4 expression (not shown).
doi:10.1371/journal.pone.0009982.g004
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some indication that cytochalasin increased CXCR4/5T4 expres-
sion at the cell surface. The observation that following actin
depolarization5T4and CXCR4remainattheplasma membraneis
consistent with several reports implicating actin binding proteins in
CXCR4 internalization and degradation[38]. For example, actin
binding cortactin and plectrin have been shown to be involved in
CXCL12 induced CXCR4 internalization and recycling in
HEK293 cells overexpressing CXCR4 [39,40]. Also, myosin IIA,
a molecular motor involved in vesicle and protein trafficking along
actin filaments, requires its actin binding domain for efficient
endocytosis of CXCR4 [41]. Therefore the disruption of the
cytoskeleton mayhavediminishedtheabilityof5T4and CXCR4to
beendocytosedandsubsequentlydegradedinthelysosomesthereby
increasing their stability and half-life at the cell surface.
The 5T4 gene is highly conserved across different vertebrate
species and the TM region is completely conserved (Figure 12A).
This explains why the human 5T4 and mouse 5T4 genes could
equally restore CXCR4 cell surface expression in 5T4KO cells.
Chemokine receptors, G-protein-coupled seven TM spanning
proteins, are also highly conserved in evolution [42], with the
hydrophobic amino acids of TM domains forming a-helical
structures which anchor the receptors in the membrane [43].
Current understanding of the mechanisms of CXCL12-CXCR4
interaction support a two step mechanism where by the initial
interaction occurs between the ligand b-sheet and its 50S and N-
loop and the CXCR4 extracellular region which facilitates rapid
binding and efficient anchoring on the extracellular side of the
receptor [44]. The ligand N-terminus remains highly dynamic and
searches for the binding cavities buried with the receptor TM
helices. This second step interaction between the ligand N-
terminus and the receptor TM region triggers conformational
changes in the CXCR4 TM to induce G-protein signaling [44].
Importantly, the chemotactic response of both differentiated ES
cells and MEF can be blocked by some but not all antibodies
recognizing distinct parts and epitopes of m5T4 molecules. These
data suggest that 5T4 contributes to functional integrity of the
CXCR4 receptor expression at the cell surface. 5T4 antibody
induced modulation of 5T4 molecules from the cell surface or
prevention of CXCR4/5T4 co-localization do not appear to
account for observed inhibition of some m5T4 mAbs. It seems
more likely that the inhibition results from allosteric effects on
CXCR4 altering the nature of ligand binding or its consequences.
Since chimeric CD44/5T4TM molecules are functional in
facilitating CXCR4 membrane expression and chemotactic
response one might conclude that the 5T4 specific antibodies
are unlikely to influence the initial direct binding of CXCL12. The
most efficient inhibitory antibody (B1C3) showed differential
activity in ELISA and western blotting of m5T4-Fc compared to
the other mAbs, consistent with an epitope influenced partly by
the presence of the 5T4 TM domain. It is possible that the 5T4
transmembrane region specifically recognizes intramembrane
residues of CXCR4 and contributes not only to the stability of
the CXCR4 expression in the plasma membrane but possibly also
to conformational changes in the receptor which govern
responsiveness to ligand. The latter may be influenced by binding
Figure 5. Disruption of cytoskeleton and CXCL12 dependent signaling in 5T4KO MEF. WT MEF exhibited an increase in ERK
phosphorylation in response to CXCL12 stimulation that was prevented by the MEK1 inhibitor PD98059 (M, 50 mM) and the CXCR4 inhibitor
AMD3100 (C, 10 mM) but not by the PI3K inhibitor LY294002 (P, 50 mM). 5T4KO MEF did not respond to CXCL12 stimulation, and this lack of response
was specifically related to CXCR4 function and not due to a generalized disruption of MAPK/ERK signaling as both WT and KO MEF exhibited an
increase in ERK1/2 phosphorylation in response to PMA stimulation, which was blocked by MEK1 inhibition but independent of both CXCR4 and PI3K
activity. Total ERK was used as a loading control.
doi:10.1371/journal.pone.0009982.g005
5T4 Regulates CXCR4 Chemotaxis
PLoS ONE | www.plosone.org 9 April 2010 | Volume 5 | Issue 4 | e9982Figure 6. The transmembrane domain of 5T4 is necessary for CXCR4 cell surface expression. (A), 5T4KO MEF were transduced with
retroviral vectors encoding both eGFP and full length or truncated 5T4 or chimeric 5T4/CD44 constructs. Successful infection was assessed by GFP
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of the 5T4 molecules. It is also conceivable that the 5T4-CXCR4
interaction may also influence receptor fate by modulating
internalization events controlled by b-arrestin binding to the
activated receptor or of targeting for degradation by preventing
ubiquination and trafficking through early endosomes to the
lysosome or by providing opportunity for recycling to the cell
surface through the 5T4 PDZ motif which is a mechanism used by
some other G protein binding receptors [27]. Indeed, 5T4
molecules also influence aspects of cytoskeletal organization
expression and the location of CXCR4, assessed in these cells. Cell surface expression of CXCR4 is only seen with constructs containing 5T4 TM (viii,
xvi, xxiv); the extracellular and cytoplasmic domains of 5T4 are not required. (B), Consistent with this CXCL12 chemotaxis of the retrovirally
transduced GFP+ 5T4 null MEF with 5T4 extracellular domain, (dark grey), 5T4 extracellular domain CD44 transmembrane and cytosolic domains,
(grid) and mock infected, (white) showing no affect whereas full length 5T4, (light grey), 5T4 extracellular and transmembrane domains, (spots) and
CD44 extracellular domain 5T4 transmembrane and cytosolic domains, (stripes) show comparable levels to wild-type (black columns).
doi:10.1371/journal.pone.0009982.g006
Figure 7. Effects of cytoskeleton, microtubule and Golgi disruption on the co-localisation pattern of 5T4 and CXCR4. Primary murine
embryonic fibroblasts were assessed for their pattern of 5T4 and CXCR4 expression by immunofluorescence following 24 hours disruption of either
the cytoskeleton (cytochalasin D), Golgi (brefeldin A) or microtubules (nocodazole) and 1 hour after drug washout. Cell surface expression of 5T4
(green) and CXCR4 (red) with regions of co-localization of the two antigens (seen as yellow) (also shown by co-localization analysis) are depicted.
doi:10.1371/journal.pone.0009982.g007
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be an integrated component of chemotactic response/motility.
These possibilities require further investigation.
We have shown that in differentiating ES cells and MEF,
CXCR6 response to CXCL16 is also 5T4 dependent. However,
CXCR3 and its response to CXCL10 is not 5T4 dependent and
CXCR7 is constitutively expressed at the cell surface in
undifferentiated ES cells. Interestingly, the LRR-containing
protein LRRC4 has been reported to regulate both the expression
and signal conduction of the CXCR4 receptor. Introduction of
LRRC4 into glioblastoma cells reduced CXCR4 expression,
CXCL12-induced ERK and AKT phosphorylation and matrix
metalloproteinase expression [45]. Crucially, the TM regions of
5T4 and LRRC4 are similar but contain significant differences
(Figure 12B). Absence of another membrane protein, Robo1, or of
its ligand Slit was also shown to up-regulate the CXCL12/
CXCR4 signaling in mammary epithelium [46]. Robo 1 has a
distinct TM domain from 5T4. All these observations point to
multiple and complex control of CXCL12/CXCR4 signaling
which may have developmental stage- or tissue-specific elements.
The delineation of embryonic cells with distinct chemotactic
responses and where 5T4 expression is one of the controlling
factors is consistent with early differentiation of ES cells being
representative of events around implantation of the embryo at
which point 5T4 expression is first detected [47]. The role of
auxiliary proteins in receptor expression and function is not
unprecedented. For example certain G protein-coupled receptors
associate with receptor activity modifying proteins (RAMPs) which
are required for receptor trafficking, ligand binding and receptor
specificity [48].
Figure 8. Characterization of m5T4 specific mAbs. (A), Summarizes the IgG subclasses of five m5T4 specific monoclonal antibodies (mAb, made
in 5T4KO mice) recognizing distinct epitopes in the proximal and distal 5T4 extracellular LRR containing domains. (B), Shows titration of mAb activity
in m5T4 specific ELISA [27]. (C), Shows titration of mAb cell surface labeling of B16m5T4 tumor cells by flow cytometry. (D), Western blot analysis of
mAb probing against recombinant m5T4-pIg showing recognition of m5T4 by all mAbs except B1C3.
doi:10.1371/journal.pone.0009982.g008
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PLoS ONE | www.plosone.org 12 April 2010 | Volume 5 | Issue 4 | e9982Figure 9. Inhibition of chemotaxis by monoclonal antibodies recognizing 5T4. (A), The chemotactic migration exhibited by differentiating
WT-ES cells towards CXCL12 was abolished in the presence of the m5T4 specific mAb B1C3 (10 mg) but not in presence of mAb P1C9 or P1H10
(10 mg) or an irrelevant control antibody (10 mg). MAbs B3F1 and B5C9 (10 mg) reduced the chemotactic response. (2 = no CXCL12, + = 10ng
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5T4 molecules. 5T4 cannot be an absolute requirement for
CXCR4 activation because 5T4 knockout mice are viable,
whereas both CXCL12 and CXCR4 KOs are lethal [49,50].
Clearly, there must be some redundancy and other molecules must
be able to regulate CXCR4 trafficking to and/or retention at the
cell surface. Additionally, there is mounting evidence that
chemokine receptors are able to form discrete functional units
via heterodimerisation with other G-protein coupled receptors. In
the case of CXCR4, heterodimerisation with the chemokine
receptor CXCR7, which binds the same ligand CXCL12, can
alter both the kinetics and the dynamics of CXCR4 responsiveness
to CXCL12 [51].
CXCL12 is a homeostatic chemokine that, unlike other ELR-
CXC chemokines, is angiogenic. CXCL12 binds to the widely
expressed CXCR4 (exclusively) and the more restricted CXCR7
(which also binds CXCL11) [26]. CXCL12 through CXCR4
regulates cardiac and neuronal development, stem cell motility,
neovascularisation and tumorigenesis [23]. Besides acting as a
cofactor for HIV, CXCR4 mediates the CXCL12-directed
migration of cancer cells to metastatic sites through the promotion
of angiogenesis and migration of tumor cells in breast, lung,
ovarian, renal, prostate and neuroblastoma [22,23,24]. It is
significant that all these tumor types are known to express the
5T4 glycoprotein [2,9,52]. Importantly, these CXCR4-positive
tumors preferentially spread to tissues with high levels of CXCL12
such as lung, liver, lymph nodes, brain and bone marrow which
are key metastatic sites [22,23,24]. In addition, the stromal
environment (often 5T4 positive [2,7,8]) can have a tumor-
imprinted promotional influence [53]; and chemokines can
sometimes induce proliferation rather than chemotaxis enhancing
tumorigenesis [26,54]. We have investigated the relationship
between expression of 5T4, CXCR4 and chemotaxis in several
human tumor cell lines including choriocarcinoma, breast and
ovarian and all exhibited CXCL12-mediated chemotaxis and
showed evidence of a 5T4/CXCR4 complex in the cell
membranes (Southgate et al., unpublished). The regulation of
CXCR4 surface expression by 5T4 molecules may provide a new
way to control response to the chemokine CXCL12 in normal
circumstances but could be selected to advantage the spread of a
tumor from its primary site. If the latter events are preferentially
and constitutively expressed properties of tumors then targeting
the CXCR4/5T4 complex might offer new opportunities for
therapeutic intervention.
Materials and Methods
Ethics Statement
All animal work was performed in accordance with the UK
Animal Scientific Procedures Act 1986 and was covered by both
Project and Personal licences that were issued by the Home Office
and reviewed by the Paterson Institute for Cancer Research
ethical committee. Professor Peter L Stern Home Office Project
Licence numbers 40-2666 (years 2003–2008) and 40/3200 (years
2008–2013) and Named Animal Care & Welfare Officer Licence
number 40/3085 covered all procedures and breeding. Local
Ethics Committee approval was provided prior to submission of all
subsequently approved project licence applications. Ethical
Review Process advises the Certificate Holder regarding Project
licence applications and standards of animal care and welfare; they
also develop initiatives leading to the widest possible application of
the 3Rs so that procedures are refined to minimise suffering,
numbers of animals used are reduced and animal use is replaced
wherever possible. Mice are housed in individually ventilated
cages. These cages prevent the spread of potential disease from
one cage to another and each cage has an individual Hepa filtered
air supply that gives approximately 72 air changes per hour and a
fixed exhaust system. All the cages are provided with environ-
mental enrichment, in the form of nesting material, a variety of
mouse houses, wooden chew blocks or play tunnels. The addition
of these items increases socialisation and environmental stimula-
tion for the mice and reduces aggression amongst some strains of
males. Routine health screening from our colonies is performed to
ensure that the mice are free from a list of specific pathogens (SPF)
and any new strains brought into the unit are health screened
before introduction into the facility.
5T4 Knockout (KO) mice
We have constructed a 5T4KO mouse by replacing the second
exon of 5T4, which encodes the entire protein, with an IRES-
LacZneo reporter gene in ES cells. These cells were used to
produce chimeric mice and germline progeny; 5T4 KO
heterozygote mice were backcrossed to the C57BL/6 background.
The 5T4KO C57BL/6 animals are viable but adult animals show
some structural disorganization within the brain and exhibit a high
frequency of hydrocephalus. The frequency of hydrocephalus is
approximately 13%, with the median age of death, (animals
requiring termination) at 49 days, (range 38–83). We have made
and characterized 5T4KO ES cells in order to study aspects of the
role of 5T4 in EMT [16]. The 5T4KO mice were used to generate
monoclonal antibodies specific for m5T4 (B3F1 (IgG2a); B5C9
(IgG1); B1C3 (IgG2a); P1C9 (IgG2b) and P1H10 (IgG2b). Primary
murine embryonic fibroblasts (MEF) of all three genotypes were
prepared from day 13 embryos following mating of male and
female 5T4 heterozygote C57BL/6 transgenic mice by methods
previously described [55].
Cell lines
E14TG2a [56], (here referred to as WT-ES) and 5T4KO-ES
cells [16] were cultured on pre-prepared 0.1% gelatine (Sigma)
coated tissue culture flasks. ES cells were grown in Knockout
DMEM, (Invitrogen) supplemented with 10% Hyclone fetal calf
serum, (Perbio), 2 mM L-glutamine, 1% non-essential amino
acids, (Sigma), nucleosides [6 ml of the following solution/500 ml
DMEM: adenosine, (80 mg), guanosine, (85 mg), cytidine,
(73 mg), uridine, (73 mg) and thymidine, (24 mg) dissolved in
100 ml double distilled water; Sigma], 2-mercaptoethanol,
(50 mM; Invitrogen), leukemia inhibitory factor, (LIF; 1000
units/ml of ESGRO; Chemicon Int.), 100 units/ml penicillin
and 100 mg/ml streptomycin (Gibco). For differentiation cells were
grown in media that was not supplemented with LIF. Media was
changed daily. MEF, A9 fibroblast cell lines, B16neo and
B16m5T4 melanoma cell lines [57,58] were cultured in DMEM
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100
units/ml penicillin and 100 mg/ml streptomycin.
The hybridoma cell lines producing the anti-m5T4 monoclonal
antibodies B5C9, P1H10, P1C9, B1C3 and B3F1 were cultured in
DMEM supplemented with heat inactivated 10% fetal calf serum
CXCL12). (B), MAb dose response of inhibition of chemotaxis towards CXCL12 in differentiating WT-ES cells. (C), The chemotactic migration exhibited
by primary WT MEF was abolished in the presence of the m5T4 specific mAb B1C3 (10 mg) but not in presence of mAb P1C9 (10 mg) or an irrelevant
control antibody (10 mg). MAbs B3F1 and B5C9 (10 mg) reduced the chemotactic response.
doi:10.1371/journal.pone.0009982.g009
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100 mg/ml streptomycin solution and maintained at 37uCi na
humidified atmosphere of 5% CO2/95% air. The hybridoma
supernatant was clarified by centrifugation and proteins concen-
trated by precipitation with 45% saturated ammonium sulphate,
dialysed extensively against PBS and antibodies purified on protein
G chromatography (HiTrap protein G column, GE Lifesciences;
[58]). The antibodies eluted with 100 mM glycine (pH 2.5) into
1 M Tris salt (pH 9) were dialysed against PBS and used for
subsequent assays.
Characterization of m5T4 specific monoclonal antibodies
Monoclonal antibodies were epitope mapped by FACS analysis
performed against A9 cell lines bearing variant constructs of 5T4;
m5T4, m/h5T4 or h/m5T4 chimeric constructs [59]. These cell
lines were transfected with pCMVa neo constructs bearing either
the full length m5T4, LRR1 of murine 5T4 fused to LRR2 of
human 5T4 or LRR1 of human 5T4 fused to LRR2 of murine
5T4 respectively and maintained with 1mg/ml G418 selection
(Sigma). Cells were suspended in FACS buffer (PBS, 0.2% bovine
serum albumin, 0.1% sodium azide) and labelled with the
appropriate concentration of anti-m5T4 monoclonal antibodies
diluted in FACS buffer for 30 mins on ice, washed with FACS
buffer and labelled with rabbit anti-mouse IgG conjugated to
FITC (Dako, 1:40). 10,000 events were acquired using a Becton
Dickinson FACScan and the data obtained was analysed using
WinMIDI (version 2.8) software.
Anti-m5T4 monoclonal antibodies were titrated by doubling
dilution between 0 and 0.1 mg/ml by sandwich ELISA. 96-well
ELISA plates (Falcon) were pre-coated at 4uC overnight with
1 mg/ml m5T4-pIgFc [58] in borate buffer (100 mM boric acid
150 mM NaCl; pH 8.5). All subsequent steps were performed at
37uC for 1 hour and the plates were washed three times with PBS
containing 0.05% Tween 20 (Sigma; PBST) between each step.
Non-specific binding was blocked using 2% low fat dried milk
(marvel) in PBST (blocking buffer) at 37uC for 2 hours. Antibody
binding was detected using goat anti-mouse IgG conjugated to
HRP (Sigma, 1:1000) in blocking buffer. The plates were
Figure 10. Influence of 5T4 on the chemokine receptors CXCR6 and CXCR3 in ES cells. (A), The expression and cellular localization of 5T4
and CXCR6 molecules on undifferenetiated and differentiating WT-ES cells was determined. Both molecules can be detected at the cell surface in
differentiating cells with some areas of co-localization (5T4 = green; CXCR6 = red; composite, co-localisation = yellow; co-localized areas shown in
separate channel). (B), Undifferentiated (white columns) and differentiating (black columns) ES cells were placed in a gradient of chemokine CXCL16
or not. (C), Immunofluorescence detection of 5T4 and CXCR3 in differentiating WT and 5T4KO-ES cells (5T4 = green, CXCR4 = red). Cell surface
expression of 5T4 is present only on differentiating WT-ES cells whilst cell surface expression of CXCR3 is evident in both undifferentiated and
differentiating WT and KO ES cells. (D), Undifferentiated WT (white columns) and 5T4KO (black columns) ES cells exhibit no CXCL10 dependent
chemotaxis but differentiating WT and 5T4KO-ES cells, acquire significant chemotaxis towards CXCL10.
doi:10.1371/journal.pone.0009982.g010
Figure 11. 5T4 is not required for CXCR7 surface expression. Immunofluorescence detection of 5T4 and CXCR7 in undifferentiated and
differentiating WT and 5T4KO-ES cells (5T4 = green, CXCR7 = red). Cell surface expression of CXCR7 is high in undifferentiated ES cells (either WT or
5T4KO). In 3 day differentiating WT-ES cells, CXCR7 is relatively downregulated from the cell surface whereas in differentiating 5T4KO-ES surface
CXCR7 is retained.
doi:10.1371/journal.pone.0009982.g011
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reaction was stopped with 1 M sulphuric acid and the absorbance
read at wavelength 450–650 nM. The isotypes of the monoclonal
antibodies were determined using Isotyping kit (ISO-2; Sigma)
according to the manufacture’s instructions.
Microarray analysis
We utilized the associated loss of pluripotency of murine ES
cells with the early upregulation of 5T4 expression to search for
other changes in gene expression using an Affymetrix approach
[18]. The ES cells were grown with or without LIF for 3 days and
the disaggregated cells sorted for expression of cell surface 5T4.
E14 TG2a cells were investigated with samples showing minimal
intra-replicate variance. Data were preprocessed using RMA[60],
as implemented in the ‘affy’ BioConductor library[61] and then
analysed using LIMMA [62] to identify those probesets found
differentially expressed between pluripotent and differentiated
samples (FDR threshold =0.1; log2 fold change threshold =1).
Resultant probesets mapped to gene identifiers using the
annotation packages in BioConductor.
Chemotaxis assay
Chemotaxis was assessed using transwell chambers as previously
described for cellular motility assays [16]. Costar Transwell 24-
well plates exhibiting 5-mm pore size were used for all motility
assays (Cambridge, MA). Briefly, for ES cells migration assays the
transwells were immersed in gelatine solution overnight (0.1% in
PBS) and rinsed in PBS. Transwells were blocked in fetal calf
serum (FCS)-containing ES cell medium or for MEF migration
assays FCS containing DMEM for 30 min at 37uC/5% CO2 and
washed in PBS. ES cells and MEF were cultured as described
above harvested and resuspended in culture medium (ES cells
=1 610
5 cells/ml, MEF =1610
4 cells/ml), and 100 ml of this
suspension was added to the transwell plates onto a preformed
chemotactic gradient (CXCL12, ES cells =10 ng, MEF =30 ng;
CXCL10, ES cells =100 ng; CXCL16, ES cells =10 ng) and
incubated overnight at 37uC/5% CO2. In all experiments there
was no evidence of differential plating with varying conditions;
chemotaxis was presented as a ratio with or without the
chemokine. The transwells were then washed gently in PBS, and
cells were removed from within the transwell using a dry cotton
bud followed by two washes in PBS. This washing procedure was
repeated twice. The transwells were stained with crystal violet for
10 min, washed in water, and allowed to air dry. Cells present on
the underside of the transwell (i.e., migrated cells) were counted by
microscopy. The number of cells on the bottom of the plate (i.e.,
cells that had migrated through the pores and become detached
from the transwell) was also counted. P values were calculated
using unpaired Student’s t test. All chemotactic experiments were
performed at least three times with triplicates for each condition.
Inhibition studies were performed in the presence of 10 mM
Diprotin A, (Sigma) for CD26, 10 mM AMD3100 (Sigma) for
CXCR4, 10 mg/well mouse antibody to CXCL12, (R&D systems),
or 0.1–10 mg/ml of the monoclonal antibodies specific for m5T4.
Specificity of mAb m5T4 mediated inhibition of chemotaxis was
validated using m5T4-IgFc fusion protein [58].
ELISA for CXCL12
The concentration of CXCL12 in 3 day conditioned medium
from undifferentiated (+LIF) or following 3 days differentiation
(-LIF) of WT- and 5T4KO-ES cells was determined by murine
CXCL12 specific ELISA (R&D systems).
Flow cytometry
Cell surface detection of human and murine 5T4 was
performed as previously described [15,16]. Briefly, cells were
trypsinized, washed twice in PBS and resuspended at 2610
6 cells/
ml in FACS buffer, (0.1% sodium azide, Sigma; 0.2% bovine
serum albumin, Sigma; in PBS). Cells were labeled with antibodies
at 4uC for 1 hour using monoclonal antibody (mAb) anti-SSEA-1-
PE (phycoerithrin,) or mouse IgM isotype-PE control at 2 mg/ml
(Santa Cruz)); rat anti-mDPIV(CD26)-PE, 5 mg/ml (R&D systems)
or rat IgG2A isotype control-PE 5 mg/ml (R&D systems); mAbs
recognizing m5T4: 9A7 (rat IgG2a [58] 20 mg/ml) and/or B3F1
(mouse IgG2a,1mg/ml), B5C9 (mouse IgG1 10 mg/ml); B1C3
(mouse IgG2a 10 mg/ml); P1C9 (mouse IgG2b 1 mg/ml) and
P1H10 (mouse IgG2b 10 mg/ml); and their respective isotype
controls rat IgG2a, mouse IgG1, mouse IgG2a and mouse IgG2b
(eBioscience). Secondary antibodies were PE-donkey anti rat,
1 mg/ml (eBioscience); PE-goat anti-mouse, 1 mg/ml (DAKO).
After washing twice in FACS buffer cells were fixed in 300 ml1 %
p-formaldehyde in PBS. In situ immunoflurescence was usually
performed for CXCR4 detection as the molecules can be sensitive
to trypsin treatment.
Modulationof 5T4 expression by mAbs
5610
5 B16m5T4 cells were incubated with either 1 mg/ml
P1C9, 10 mg/ml B1C3, 10 mg/ml mouse IgG in DMEM
supplemented with 10% FCS or media only at 37uC overnight.
Cells were washed twice with FACS buffer and all of the following
steps were performed in 0.1% sodium azide on ice. Cells were
washed twice with FACS buffer and incubated with either
biotinylated B3F1 (2 mg/ml), biotinylated B5C9 (25 mg/ml) or
FACS buffer at 4uC for 45 mins. Cells were then washed twice and
labeled with streptavidin PE (BD, 1:100) at 4uC for 45 mins.
Following two washes, cells were fixed in 1% p-formaldehyde in
PBS and analyzed using a Becton Dickinson FACScan. 10,000
events were acquired and the data obtained was analyzed using
WinMIDI (version 2.8) software.
Figure 12. Sequence comparison of 5T4 TM domains. Align-
ments were performed using the ClustalW2 multiple sequence
alignment program (EMBL-EBI) to compare (A), the TM domains of
5T4 across species and (B), the TM domain of human 5T4 with human
LRRC4, identical residues shaded black, similar residues shaded grey.
doi:10.1371/journal.pone.0009982.g012
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For each RNA sample, 2 mg of total RNA was reverse
transcribed according to manufacturer’s instructions, (Promega).
Murine primers were designed using Primer Express 2.0 (read 5’ to
3’; forward-F, reverse-R):
m5T4-F: agctcttcggtaccctcgtc,
m5T4-R: gttgcggttcacgcactta,
mCD26-F: ggcaatttgtaaaaatgggatt,
mCD26-R: aggttacataccctccatatgacc,
mCXCL12-F: tccaaattccccagcaga,
mCXCL12-R: ctgaacccatcgctgcttagac,
mCXCR4-F: caggacctgtggccaagttctt,
mCXCR4-R: agctgaggatcacggctagctt.
SybrGreen qPCR reactions were performed in MicroAmp
optical 384-well reaction plates, (Applied Biosystems). Amplifica-
tions were carried out using a 7900 ABI Prism thermocycler,
(Applied Biosystems) and amplification analyzed with SDS 2.1
software, (Applied Biosystems). Melt curves (derivative of fluores-
cence intensity versus temperature) were made and inspected to
ensure that only one peak, indicating one amplicon product, was
produced. Amplification efficiencies for each primer pair were
determined by constructing standard dilution curves (mean Ct of
triplicate reactions plotted against cDNA mass), with cDNA inputs
of 1 ng, 5 ng, 10 ng, 50 ng and 100 ng per reaction and
calculating r
2 values and gradients of linear regression lines. For
testing of relative gene expression, 10 ng cDNA was used per
reaction
SDS-Polyacrylamide Gel Electrophoresis (PAGE) and
Western Blotting
Samples were prepared in non-reducing PAGE loading buffer
(Thermo Fisher), heated to 100uC for 3 minutes and loaded on to
a preformed 10% or 4-15% gradient gel (BioRad) and run in
Lamelli buffer (25 mM Tris-base, 192 mM glycine, 0.1% SDS).
Western transfer to PVDF membranes used a BioRad Mini-
PROTEAN Tetra cell system. For western probing, primary
antibody concentrations were: Polyclonal rabbit anti-CXCR4,
(1 mg/ml) (Abcam) and appropriate concentrations of the different
mouse 5T4 specific monoclonal antibodies. For the detection of
phosphorylated and/or intracellular proteins cells were lysed in M-
PER supplemented with protease and phosphatase inhibitor
cocktails, (Thermo Fisher). The compounds PD98059 (50 mM),
LY294002 (50 mM) (both Cell Signaling Technology) or
AMD3100 (10 mM) were applied to cells for 1 hour prior to
CXCL12 (12.5 nM) or Phorbol 12-Myristate 13-Acetate, (PMA)
(50 nM) (Sigma) stimulation in order to inhibit MEK1, PI3 kinase
or CXCR4 respectively. Primary antibodies used as per suppliers
instructions were ERK1/2, phospho-ERK1/2 (Thr202/Tyr204),
(Cell Signalling Technology). Following secondary antibody
labeling using appropriate HRP conjugates, (AbSerotec) hybrid-
izing bands were detected using SuperSignal West Dura, (Thermo
Fischer).
Immunofluorescence in situ
These studies were performed using methods described
previously [63], with cells grown on 24 well glass bottomed plates,
(Iwaki, supplied through Jencons) coated with 0.1% gelatine.
Primary antibodies used were rabbit anti-CXCR4, (5 mg/ml)
(Abcam), rat-anti-DPIV (5 mg/ml), (R&D), mAb anti-m5T4, 9A7
(20 mg/ml), B5C9 or B3F1 (5 mg/ml) or appropriate isotype
controls. Secondary detection was performed by incubation for 1
hour at 4uC with species or IgG sub-class specific Alexa Fluor
conjugated secondary antibodies (Invitrogen) (6 mg/ml) as appro-
priate for multiple antigen detection. Labeling of the endoplasmic
reticulum and Golgi apparatus was performed using C6-Ceramide
or Endotracker, (Invitrogen, Molecular Probes) as per manufac-
turer’s instructions. Labeling of lipid rafts was performed using
cholera toxin subunit B conjugated to FITC, 1 mg/ml (Sigma) for
30 minutes at room temperature after secondary antibody
labeling. F-Actin was labeled using Phaloidin-633 Alexa Fluor
(Invitrogen). Inhibition of the Golgi, actin cytoskeleton and
microtubule network was performed by overnight incubation of
MEF with optimized concentrations of 3.57 mM Brefeldin FA,
985 nM Cytochalasin D or 332 nM Nocodazole respectively.
Cells were fixed following washout at 0, 30 minutes and 1 hour
and processed as above for immunofluorescence. Cytoskeleton
disruption following 24 hours treatment with cytochalasin D was
achieved as no polymerized actin filaments were detectable (data
not shown). Likewise, Golgi disruption following brefeldin A
treatment was confirmed by immunofluorescence detection of
sphingolipids using BODIPY labeled NBD C6 ceramide (data not
shown). Microtubule disruption following nocodazole treatment
was confirmed by immunofluorescence detection using an
antibody against b-tubulin (data not shown). In some experiments,
MEF were seeded and treated with 332 nM nocodazole for 18
hours and following washout, cells were incubated in growth
medium or growth medium with mAb B1C3 and P1C9 (10 mg/
ml) or mIgG (10 mg/ml) for 3 or 6 hours.
Cells were imaged on a Zeiss Axiovert 200 M with a plan-fluar
6100 1.45NA objective lens and a Roper Cascade EMCCD 512B
camera. Illumination was achieved using a 300W Xenon system,
(Sutter) which presented the system as an even field of illumination
in addition to the appropriate neutral density and Schott filters to
modulate the light source. Wavelength selection was achieved
using external filter wheels, (Applied Scientific Instrumentation)
and the ET-Sedat set, (Chroma). Data sets were captured with an
axial resolution of 100 nm using the MS-2000 stage (Applied
Scientific Instrumentation) and a lateral resolution of 0.1645
microns per pixel. The system was full controlled and automated
via the FRAP-AI software, (MAG Biosystems/Metamorph). All of
the data sets were deconvolved using Huygens (Scientific Volume
Imaging) after which visualization and analysis was carried out
using Imaris, (Bitplane). Deconvolved images were assessed
utilizing the ImarisColoc software (Bitplane) in manual mode. A
2D scatter plot showing intensity pairs in the image was
thresholded to include only co-localized points in the three
dimensional volume. This data was then extracted to a separate
channel containing three dimensional co-localized points only.
For each in situ immunofluorescence investigation, a minimum
of 50 cells per experimental condition were examined in at least
duplicate. In addition a more detailed quantitative analysis (as
above) of the patterns of expression (e.g. intracellular versus
membrane) was performed on between 10–25 cells and represen-
tative images are presented.
5T4 constructs
A series of 5T4 constructs were built for this study and cloned
into pCMVa, and the retroviral vector SFb91 [64] containing a
cDNA cassette eGFP under the transcriptional control of an IRES,
(Clonetech). Chimeric constructs of mouse 5T4/CD44 molecules
with reciprocally exchanged TM and cytoplasmic domains were
engineered. CD44 molecules are 80–95 kDa transmembrane
glycoproteins expressed on a variety of normal cells as well as
some tumors where particular spliced forms have been associated
with increased metastasis [65]. E1/E3 replication deficient
recombinant adenoviral vectors were constructed by cloning of
the m5T4 or h5T4 cDNA into the adenoviral shuttle vector
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sub-cloning of the eGFP cDNA into the pAdlox vector.
Recombinant adenoviral particles, (hereafter termed RAd-m5T4,
RAd-h5T4 and RAd-GFP) were generated by co-transfection of
CRE8 cells with the pAdlox vector and adenovirus C5 DNA as
described [66]. High-titre stocks were prepared by double cesium
chloride density gradient separation and titred as previously
described [63]. Viral stocks were found to be free of replication-
competent adenovirus using a supernatant rescue assay using
HeLa cells able to detect 1 replication-competent virus within 10
9
recombinant viruses [63]. A multiplicity of 30 infectious units per
cell led to 100% of cells expressing m5T4 or h5T4 or GFP at 48
hours as assessed by FACS and when other biological assessments
were made.
Statistical analysis
Quoted errors refer to standard errors of the mean. Statistical
significance was calculated by either two-tailed unpaired Student t-
test or ANOVA test as appropriate.
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